Janney Montgomery Scott
GNMX

Janney Montgomery Scott’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Janney Montgomery Scott’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-41,923
Closed -$338K – 2179
2015
Q1 		$338K Buy
41,923
+2,250
+6% +$17K 0.01% 1675
2014
Q4 		$201K Buy
39,673
+7,000
+21% +$34.6K ﹤0.01% 2013
2014
Q3 		$170K Buy
32,673
+9,600
+42% +$61.9K ﹤0.01% 2040
2014
Q2 		$179K Sell
23,073
-2,750
-11% -$19.4K ﹤0.01% 1990
2014
Q1 		$180K Buy
25,823
+6,000
+30% +$46.9K ﹤0.01% 1811
2013
Q4 		$119K Buy
19,823
+5,700
+40% +$37.3K ﹤0.01% 1885
2013
Q3 		$110K Buy
+14,123
New +$65.6K ﹤0.01% 1801

Other funds holding GNMX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Janney Montgomery Scott's GNMX Position: Q2 2015 in Review

Janney Montgomery Scott sold out of Aevi Genomic Medicine Inc (GNMX) in Q2 2015, closing a stake of 41,923 shares — an estimated $338K sold.

Janney Montgomery Scott first reported a position in GNMX in Q3 2013 and held it in 7 quarters. The position peaked at $338K in Q1 2015. 54 funds tracked by Wall St. Rank hold GNMX as of Q2 2015.

  • Janney Montgomery Scott reported no remaining Aevi Genomic Medicine Inc position as of Q2 2015 after selling out during the quarter.
  • Janney Montgomery Scott sold 41,923 Aevi Genomic Medicine Inc shares in Q2 2015, an estimated $338K.
  • Janney Montgomery Scott first reported a position in Aevi Genomic Medicine Inc in Q3 2013 and held it in 7 quarters.
  • Janney Montgomery Scott's Aevi Genomic Medicine Inc position peaked at $338K in Q1 2015.
  • 54 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q2 2015.

Based on Janney Montgomery Scott's 13F filing for Q2 2015, filed 4 Aug 2015.